| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Antineoplastic Agents, Phytogenic | 28 | 2019 | 183 | 10.80 | Why? |
| Drug Resistance, Neoplasm | 37 | 2019 | 447 | 9.55 | Why? |
| Drug Resistance, Multiple | 21 | 2019 | 156 | 6.99 | Why? |
| Plant Extracts | 27 | 2021 | 1514 | 4.50 | Why? |
| Plants, Medicinal | 14 | 2021 | 622 | 4.44 | Why? |
| Artemisinins | 12 | 2018 | 238 | 3.83 | Why? |
| Cell Line, Tumor | 44 | 2019 | 3608 | 3.03 | Why? |
| Phytochemicals | 12 | 2021 | 678 | 2.95 | Why? |
| Fabaceae | 4 | 2019 | 39 | 2.69 | Why? |
| Apoptosis | 18 | 2019 | 2335 | 2.35 | Why? |
| Magnoliopsida | 4 | 2018 | 36 | 2.35 | Why? |
| Alkaloids | 9 | 2019 | 255 | 2.10 | Why? |
| Naphthoquinones | 3 | 2019 | 87 | 2.10 | Why? |
| Caenorhabditis elegans | 3 | 2021 | 82 | 1.91 | Why? |
| Antineoplastic Agents | 17 | 2019 | 3550 | 1.84 | Why? |
| Leukemia | 6 | 2019 | 598 | 1.83 | Why? |
| Receptors, Serotonin | 2 | 2021 | 16 | 1.80 | Why? |
| Phytotherapy | 6 | 2018 | 743 | 1.78 | Why? |
| Withanolides | 2 | 2021 | 46 | 1.71 | Why? |
| Zanthoxylum | 2 | 2019 | 4 | 1.60 | Why? |
| Reactive Oxygen Species | 12 | 2021 | 1136 | 1.59 | Why? |
| Membrane Potential, Mitochondrial | 8 | 2019 | 102 | 1.47 | Why? |
| Doxorubicin | 7 | 2019 | 313 | 1.44 | Why? |
| Oxidative Stress | 7 | 2021 | 2050 | 1.36 | Why? |
| Isoflavones | 3 | 2019 | 52 | 1.33 | Why? |
| Isoquinolines | 5 | 2018 | 69 | 1.32 | Why? |
| Longevity | 4 | 2021 | 159 | 1.31 | Why? |
| Neuroglia | 5 | 2018 | 130 | 1.30 | Why? |
| Gene Expression Regulation, Neoplastic | 11 | 2019 | 1014 | 1.28 | Why? |
| Medicine, Traditional | 2 | 2018 | 189 | 1.25 | Why? |
| Cell Survival | 12 | 2018 | 1581 | 1.22 | Why? |
| ATP-Binding Cassette Transporters | 4 | 2019 | 48 | 1.20 | Why? |
| Monoterpenes | 4 | 2018 | 46 | 1.18 | Why? |
| Antioxidants | 7 | 2021 | 1593 | 1.16 | Why? |
| Caenorhabditis elegans Proteins | 2 | 2021 | 28 | 1.12 | Why? |
| ErbB Receptors | 4 | 2019 | 320 | 1.07 | Why? |
| Sesquiterpenes | 5 | 2018 | 77 | 1.06 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 6 | 2018 | 1573 | 1.00 | Why? |
| Molecular Structure | 16 | 2021 | 1539 | 0.99 | Why? |
| NF-kappa B | 3 | 2019 | 1301 | 0.92 | Why? |
| Synaptic Transmission | 1 | 2021 | 46 | 0.91 | Why? |
| Serotonin Plasma Membrane Transport Proteins | 1 | 2021 | 39 | 0.89 | Why? |
| Diterpenes | 3 | 2021 | 157 | 0.88 | Why? |
| Caspases | 5 | 2019 | 156 | 0.88 | Why? |
| Neoplasms | 14 | 2019 | 17251 | 0.86 | Why? |
| Terpenes | 2 | 2021 | 135 | 0.85 | Why? |
| Dioxoles | 2 | 2019 | 19 | 0.85 | Why? |
| Naphthalenes | 2 | 2018 | 94 | 0.84 | Why? |
| Antimalarials | 7 | 2018 | 2505 | 0.84 | Why? |
| Artemisia annua | 2 | 2018 | 78 | 0.82 | Why? |
| Polyphenols | 3 | 2019 | 283 | 0.81 | Why? |
| Vitamin K 3 | 1 | 2019 | 14 | 0.81 | Why? |
| Carbolines | 1 | 2019 | 7 | 0.81 | Why? |
| Indole Alkaloids | 1 | 2019 | 16 | 0.81 | Why? |
| Agkistrodon | 1 | 2018 | 2 | 0.79 | Why? |
| Eugenia | 1 | 2018 | 8 | 0.78 | Why? |
| Flavonoids | 4 | 2019 | 492 | 0.78 | Why? |
| Ocimum basilicum | 1 | 2018 | 1 | 0.78 | Why? |
| Cardenolides | 1 | 2018 | 24 | 0.77 | Why? |
| Oils, Volatile | 2 | 2018 | 127 | 0.77 | Why? |
| Trypanosomiasis | 1 | 2018 | 2 | 0.77 | Why? |
| Salvia | 1 | 2018 | 17 | 0.76 | Why? |
| Euphorbia | 1 | 2018 | 14 | 0.76 | Why? |
| Polyunsaturated Alkamides | 1 | 2019 | 40 | 0.76 | Why? |
| Cinnamates | 1 | 2019 | 50 | 0.75 | Why? |
| Daphne | 1 | 2018 | 2 | 0.75 | Why? |
| Antidepressive Agents | 2 | 2021 | 509 | 0.75 | Why? |
| Theft | 1 | 2018 | 13 | 0.75 | Why? |
| Garcinia | 1 | 2017 | 5 | 0.74 | Why? |
| Complex Mixtures | 1 | 2018 | 51 | 0.74 | Why? |
| Nepeta | 1 | 2017 | 2 | 0.73 | Why? |
| Artemisia | 1 | 2018 | 27 | 0.73 | Why? |
| Radiation-Protective Agents | 1 | 2017 | 9 | 0.73 | Why? |
| Biomarkers, Tumor | 2 | 2018 | 1314 | 0.72 | Why? |
| Biflavonoids | 1 | 2019 | 80 | 0.72 | Why? |
| Stomach Ulcer | 1 | 2018 | 101 | 0.71 | Why? |
| Cedrus | 1 | 2017 | 5 | 0.71 | Why? |
| Sirtuin 1 | 1 | 2019 | 100 | 0.71 | Why? |
| Wnt Proteins | 1 | 2017 | 38 | 0.71 | Why? |
| Cell Adhesion | 1 | 2018 | 230 | 0.71 | Why? |
| Succinates | 1 | 2018 | 79 | 0.71 | Why? |
| Kelch-Like ECH-Associated Protein 1 | 1 | 2017 | 21 | 0.71 | Why? |
| Plakortis | 1 | 2017 | 1 | 0.70 | Why? |
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 130 | 0.70 | Why? |
| Osteosarcoma | 1 | 2018 | 83 | 0.69 | Why? |
| Glioblastoma | 2 | 2018 | 187 | 0.69 | Why? |
| Drug Screening Assays, Antitumor | 7 | 2018 | 138 | 0.69 | Why? |
| Dacarbazine | 1 | 2017 | 67 | 0.68 | Why? |
| Plant Roots | 4 | 2019 | 108 | 0.68 | Why? |
| Analgesics | 2 | 2018 | 451 | 0.68 | Why? |
| Oleanolic Acid | 1 | 2018 | 82 | 0.68 | Why? |
| Aglaia | 1 | 2016 | 9 | 0.68 | Why? |
| beta Catenin | 1 | 2017 | 78 | 0.68 | Why? |
| Salicylates | 1 | 2017 | 48 | 0.68 | Why? |
| Carcinogens | 1 | 2017 | 33 | 0.67 | Why? |
| Cell Cycle | 4 | 2019 | 329 | 0.67 | Why? |
| Xenobiotics | 1 | 2017 | 37 | 0.67 | Why? |
| Porifera | 1 | 2017 | 29 | 0.67 | Why? |
| I-kappa B Kinase | 1 | 2017 | 98 | 0.66 | Why? |
| Biological Products | 6 | 2020 | 2331 | 0.65 | Why? |
| Cell Separation | 1 | 2018 | 270 | 0.65 | Why? |
| Heme Oxygenase-1 | 1 | 2017 | 90 | 0.65 | Why? |
| Drugs, Chinese Herbal | 3 | 2021 | 2760 | 0.63 | Why? |
| Protective Agents | 2 | 2018 | 250 | 0.63 | Why? |
| Saponins | 1 | 2018 | 171 | 0.63 | Why? |
| Tight Junctions | 1 | 2017 | 179 | 0.62 | Why? |
| Osteoarthritis | 1 | 2018 | 205 | 0.62 | Why? |
| DNA Viruses | 1 | 2018 | 184 | 0.61 | Why? |
| Radiation Injuries | 1 | 2017 | 140 | 0.61 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2018 | 310 | 0.61 | Why? |
| Systems Biology | 1 | 2018 | 320 | 0.61 | Why? |
| Metaphor | 1 | 2016 | 71 | 0.60 | Why? |
| Inhibitory Concentration 50 | 5 | 2019 | 907 | 0.60 | Why? |
| Phenols | 1 | 2017 | 226 | 0.60 | Why? |
| Ergot Alkaloids | 1 | 2014 | 3 | 0.60 | Why? |
| Biological Assay | 1 | 2018 | 367 | 0.60 | Why? |
| Plant Bark | 3 | 2019 | 39 | 0.59 | Why? |
| Adenosine Triphosphatases | 2 | 2018 | 78 | 0.58 | Why? |
| Caryophyllales | 3 | 2018 | 3 | 0.57 | Why? |
| Catechin | 1 | 2018 | 244 | 0.57 | Why? |
| Withania | 3 | 2021 | 55 | 0.57 | Why? |
| Bone Neoplasms | 1 | 2018 | 287 | 0.56 | Why? |
| Lactones | 2 | 2017 | 62 | 0.56 | Why? |
| Leukemia, T-Cell | 1 | 2013 | 3 | 0.56 | Why? |
| Molecular Docking Simulation | 15 | 2021 | 6902 | 0.54 | Why? |
| Drugs, Investigational | 1 | 2017 | 198 | 0.54 | Why? |
| NF-E2-Related Factor 2 | 1 | 2017 | 373 | 0.52 | Why? |
| Organoids | 1 | 2020 | 840 | 0.52 | Why? |
| Biological Transport | 1 | 2014 | 290 | 0.50 | Why? |
| Plant Leaves | 3 | 2019 | 233 | 0.50 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2018 | 526 | 0.49 | Why? |
| Membrane Transport Proteins | 1 | 2014 | 152 | 0.49 | Why? |
| Hep G2 Cells | 3 | 2018 | 391 | 0.49 | Why? |
| Animals | 28 | 2021 | 78931 | 0.48 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2015 | 265 | 0.48 | Why? |
| Rhodiola | 4 | 2018 | 16 | 0.48 | Why? |
| Gene Expression Profiling | 5 | 2018 | 3788 | 0.48 | Why? |
| Radiotherapy | 1 | 2017 | 608 | 0.47 | Why? |
| Cell Proliferation | 8 | 2018 | 1973 | 0.46 | Why? |
| Breast Neoplasms | 5 | 2018 | 3633 | 0.45 | Why? |
| Cyclohexanols | 1 | 2010 | 20 | 0.45 | Why? |
| Aptamers, Nucleotide | 1 | 2015 | 265 | 0.45 | Why? |
| Cajanus | 1 | 2010 | 1 | 0.45 | Why? |
| Eleutherococcus | 3 | 2018 | 4 | 0.44 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.43 | Why? |
| Fluoxetine | 2 | 2021 | 77 | 0.43 | Why? |
| Plant Components, Aerial | 3 | 2018 | 12 | 0.42 | Why? |
| Pain | 1 | 2018 | 1084 | 0.42 | Why? |
| Humans | 97 | 2021 | 930598 | 0.42 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.42 | Why? |
| Precision Medicine | 2 | 2018 | 1477 | 0.41 | Why? |
| Takotsubo Cardiomyopathy | 1 | 2016 | 453 | 0.41 | Why? |
| RNA Viruses | 1 | 2018 | 824 | 0.41 | Why? |
| Proteins | 1 | 2018 | 921 | 0.41 | Why? |
| Gene Knockout Techniques | 2 | 2021 | 347 | 0.41 | Why? |
| Nitric Oxide Synthase Type II | 1 | 2010 | 119 | 0.41 | Why? |
| Aspirin | 1 | 2018 | 1043 | 0.40 | Why? |
| Structure-Activity Relationship | 9 | 2021 | 2219 | 0.39 | Why? |
| Curcumin | 3 | 2020 | 396 | 0.38 | Why? |
| Guanidines | 1 | 2013 | 499 | 0.38 | Why? |
| Leishmaniasis | 1 | 2008 | 26 | 0.38 | Why? |
| Carbon-13 Magnetic Resonance Spectroscopy | 2 | 2019 | 64 | 0.37 | Why? |
| Benzopyrans | 2 | 2018 | 39 | 0.37 | Why? |
| Protein Kinase Inhibitors | 2 | 2017 | 1585 | 0.36 | Why? |
| Plasmodium falciparum | 5 | 2018 | 337 | 0.36 | Why? |
| Arthritis, Rheumatoid | 2 | 2019 | 2043 | 0.36 | Why? |
| Colitis, Ulcerative | 1 | 2017 | 1037 | 0.35 | Why? |
| Alzheimer Disease | 1 | 2017 | 1020 | 0.34 | Why? |
| DNA Damage | 3 | 2018 | 285 | 0.34 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.33 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.33 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.32 | Why? |
| Microarray Analysis | 3 | 2018 | 262 | 0.32 | Why? |
| Drug Resistance | 1 | 2008 | 395 | 0.30 | Why? |
| Neoplasm Proteins | 4 | 2018 | 501 | 0.29 | Why? |
| Biomedical Research | 2 | 2017 | 5270 | 0.29 | Why? |
| International Cooperation | 1 | 2018 | 3436 | 0.28 | Why? |
| Caco-2 Cells | 2 | 2018 | 1236 | 0.28 | Why? |
| Cell Movement | 2 | 2019 | 695 | 0.27 | Why? |
| Emotions | 1 | 2016 | 2418 | 0.27 | Why? |
| Egypt | 2 | 2018 | 1211 | 0.26 | Why? |
| Anti-Infective Agents | 2 | 2017 | 1766 | 0.26 | Why? |
| Gene Expression Regulation | 3 | 2019 | 4020 | 0.26 | Why? |
| Mitochondria | 1 | 2010 | 857 | 0.25 | Why? |
| Antiviral Agents | 8 | 2021 | 41703 | 0.25 | Why? |
| Schisandra | 2 | 2018 | 3 | 0.25 | Why? |
| Infectious bronchitis virus | 1 | 2010 | 856 | 0.25 | Why? |
| Centaurea | 2 | 2018 | 3 | 0.24 | Why? |
| Anti-Inflammatory Agents | 2 | 2018 | 6153 | 0.24 | Why? |
| Cell Cycle Checkpoints | 2 | 2019 | 126 | 0.23 | Why? |
| Chemical and Drug Induced Liver Injury | 2 | 2017 | 451 | 0.23 | Why? |
| Osmotic Pressure | 1 | 2021 | 15 | 0.23 | Why? |
| Signal Transduction | 5 | 2018 | 7207 | 0.23 | Why? |
| Multidrug Resistance-Associated Proteins | 2 | 2018 | 29 | 0.23 | Why? |
| Invertebrates | 1 | 2021 | 21 | 0.23 | Why? |
| Heat-Shock Response | 1 | 2021 | 47 | 0.22 | Why? |
| Viral Matrix Proteins | 2 | 2021 | 1243 | 0.22 | Why? |
| Cell Line | 6 | 2019 | 12040 | 0.22 | Why? |
| Animals, Genetically Modified | 1 | 2021 | 230 | 0.21 | Why? |
| Lactates | 1 | 2020 | 59 | 0.21 | Why? |
| Anthozoa | 1 | 2021 | 85 | 0.21 | Why? |
| Caffeic Acids | 1 | 2020 | 54 | 0.21 | Why? |
| Benzoquinones | 2 | 2018 | 92 | 0.21 | Why? |
| Benzofurans | 2 | 2018 | 91 | 0.21 | Why? |
| G2 Phase | 1 | 2019 | 11 | 0.21 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.20 | Why? |
| Cameroon | 2 | 2019 | 464 | 0.20 | Why? |
| Rutaceae | 1 | 2019 | 1 | 0.20 | Why? |
| Drug Evaluation, Preclinical | 5 | 2020 | 3347 | 0.20 | Why? |
| MCF-7 Cells | 2 | 2017 | 199 | 0.20 | Why? |
| Microtubules | 1 | 2019 | 47 | 0.20 | Why? |
| Cell Death | 2 | 2019 | 536 | 0.20 | Why? |
| Pulicaria | 1 | 2018 | 1 | 0.20 | Why? |
| Nuphar | 1 | 2018 | 7 | 0.20 | Why? |
| Tubulin | 1 | 2019 | 67 | 0.20 | Why? |
| Iodoacetic Acid | 1 | 2018 | 10 | 0.20 | Why? |
| Nerium | 1 | 2019 | 18 | 0.20 | Why? |
| Propidium | 1 | 2018 | 14 | 0.20 | Why? |
| Annexin A5 | 1 | 2018 | 22 | 0.20 | Why? |
| Cell Division | 1 | 2019 | 136 | 0.20 | Why? |
| Leuzea | 1 | 2018 | 2 | 0.20 | Why? |
| Arthritis, Experimental | 1 | 2019 | 44 | 0.20 | Why? |
| Bryonia | 1 | 2018 | 20 | 0.20 | Why? |
| Antitoxins | 1 | 2018 | 10 | 0.19 | Why? |
| Pharmaceutical Preparations | 1 | 2014 | 1897 | 0.19 | Why? |
| Supervised Machine Learning | 1 | 2021 | 172 | 0.19 | Why? |
| Receptors, Opioid | 1 | 2018 | 25 | 0.19 | Why? |
| Scopoletin | 1 | 2018 | 2 | 0.19 | Why? |
| Chondrocytes | 1 | 2018 | 35 | 0.19 | Why? |
| SARS Virus | 2 | 2021 | 13021 | 0.19 | Why? |
| Pentose Phosphate Pathway | 1 | 2018 | 7 | 0.19 | Why? |
| Hypertrophy | 1 | 2018 | 86 | 0.19 | Why? |
| Moraceae | 1 | 2018 | 4 | 0.19 | Why? |
| Naturopathy | 1 | 2018 | 11 | 0.19 | Why? |
| Morus | 1 | 2019 | 41 | 0.19 | Why? |
| Liquid-Liquid Extraction | 1 | 2019 | 60 | 0.19 | Why? |
| Hemidesmus | 1 | 2018 | 2 | 0.19 | Why? |
| Cartilage, Articular | 1 | 2018 | 50 | 0.19 | Why? |
| Models, Molecular | 4 | 2019 | 7616 | 0.19 | Why? |
| Colonialism | 1 | 2018 | 26 | 0.19 | Why? |
| Gluconates | 1 | 2018 | 28 | 0.19 | Why? |
| Xanthenes | 1 | 2018 | 3 | 0.19 | Why? |
| Pyrones | 1 | 2018 | 29 | 0.19 | Why? |
| Monoamine Oxidase Inhibitors | 1 | 2017 | 6 | 0.19 | Why? |
| Circular Dichroism | 1 | 2018 | 154 | 0.19 | Why? |
| Rats, Sprague-Dawley | 2 | 2019 | 987 | 0.19 | Why? |
| Leishmania | 1 | 2018 | 28 | 0.19 | Why? |
| Gallic Acid | 1 | 2019 | 49 | 0.19 | Why? |
| Quercetin | 2 | 2019 | 297 | 0.18 | Why? |
| Lignans | 1 | 2018 | 41 | 0.18 | Why? |
| HCT116 Cells | 1 | 2018 | 83 | 0.18 | Why? |
| Calcium Signaling | 1 | 2019 | 133 | 0.18 | Why? |
| Medicine, African Traditional | 1 | 2018 | 31 | 0.18 | Why? |
| Monoamine Oxidase | 1 | 2017 | 20 | 0.18 | Why? |
| Dose-Response Relationship, Drug | 5 | 2019 | 3776 | 0.18 | Why? |
| Trypanosoma brucei rhodesiense | 1 | 2017 | 2 | 0.18 | Why? |
| Larva | 1 | 2018 | 153 | 0.18 | Why? |
| Verapamil | 2 | 2018 | 46 | 0.18 | Why? |
| Nucleocapsid Proteins | 1 | 2010 | 3120 | 0.18 | Why? |
| Poliovirus | 1 | 2019 | 109 | 0.18 | Why? |
| Herb-Drug Interactions | 1 | 2017 | 28 | 0.18 | Why? |
| Flow Cytometry | 3 | 2018 | 2393 | 0.18 | Why? |
| Sesquiterpenes, Guaiane | 1 | 2017 | 4 | 0.18 | Why? |
| Plant Stems | 1 | 2017 | 23 | 0.18 | Why? |
| Flavones | 1 | 2018 | 65 | 0.18 | Why? |
| Ki-67 Antigen | 1 | 2018 | 139 | 0.18 | Why? |
| Antiprotozoal Agents | 1 | 2018 | 83 | 0.18 | Why? |
| Marsdenia | 1 | 2017 | 1 | 0.18 | Why? |
| Sumoylation | 1 | 2017 | 21 | 0.18 | Why? |
| Caspase 3 | 1 | 2018 | 218 | 0.18 | Why? |
| Osteoblasts | 1 | 2018 | 87 | 0.18 | Why? |
| Cholangiocarcinoma | 2 | 2018 | 186 | 0.18 | Why? |
| Erlotinib Hydrochloride | 1 | 2017 | 48 | 0.18 | Why? |
| Muscle Proteins | 1 | 2017 | 64 | 0.18 | Why? |
| Mice | 6 | 2019 | 21357 | 0.18 | Why? |
| Staining and Labeling | 1 | 2018 | 169 | 0.17 | Why? |
| Inactivation, Metabolic | 1 | 2017 | 16 | 0.17 | Why? |
| Trypsin | 1 | 2018 | 209 | 0.17 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2018 | 274 | 0.17 | Why? |
| Behavior, Animal | 1 | 2018 | 136 | 0.17 | Why? |
| Acids | 1 | 2017 | 22 | 0.17 | Why? |
| Dioxanes | 1 | 2017 | 14 | 0.17 | Why? |
| Ecotoxicology | 1 | 2017 | 39 | 0.17 | Why? |
| Lipid Peroxidation | 1 | 2017 | 114 | 0.17 | Why? |
| Macrophages | 1 | 2010 | 2784 | 0.17 | Why? |
| Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 159 | 0.17 | Why? |
| Cytoskeletal Proteins | 1 | 2017 | 63 | 0.17 | Why? |
| Pregnanes | 1 | 2017 | 30 | 0.17 | Why? |
| Gas Chromatography-Mass Spectrometry | 1 | 2018 | 187 | 0.17 | Why? |
| Zebrafish | 1 | 2018 | 181 | 0.17 | Why? |
| Poly(ADP-ribose) Polymerases | 1 | 2018 | 91 | 0.17 | Why? |
| Trypanosoma cruzi | 1 | 2018 | 133 | 0.17 | Why? |
| Molecular Dynamics Simulation | 4 | 2021 | 4155 | 0.17 | Why? |
| Coumarins | 1 | 2017 | 46 | 0.17 | Why? |
| Microsomes, Liver | 1 | 2017 | 96 | 0.17 | Why? |
| Receptors, CXCR4 | 1 | 2017 | 83 | 0.17 | Why? |
| Urokinase-Type Plasminogen Activator | 1 | 2017 | 62 | 0.17 | Why? |
| Quinolines | 2 | 2019 | 403 | 0.16 | Why? |
| Cisplatin | 1 | 2018 | 209 | 0.16 | Why? |
| Topoisomerase I Inhibitors | 1 | 2017 | 63 | 0.16 | Why? |
| Self Medication | 1 | 2018 | 131 | 0.16 | Why? |
| Diuretics | 1 | 2018 | 326 | 0.16 | Why? |
| Triterpenes | 1 | 2019 | 199 | 0.16 | Why? |
| Interleukin-4 | 1 | 2018 | 367 | 0.16 | Why? |
| Depression | 1 | 2021 | 14116 | 0.16 | Why? |
| Motor Activity | 1 | 2018 | 217 | 0.16 | Why? |
| Stilbenes | 1 | 2017 | 113 | 0.16 | Why? |
| Plasminogen Activator Inhibitor 1 | 1 | 2017 | 162 | 0.16 | Why? |
| Binding Sites | 5 | 2021 | 6201 | 0.16 | Why? |
| Oxazines | 1 | 2018 | 279 | 0.15 | Why? |
| Matrix Metalloproteinase 9 | 1 | 2017 | 211 | 0.15 | Why? |
| Cytochrome P-450 Enzyme System | 1 | 2017 | 144 | 0.15 | Why? |
| Carcinogenesis | 1 | 2018 | 236 | 0.15 | Why? |
| Neuroprotective Agents | 1 | 2018 | 240 | 0.15 | Why? |
| Heterocyclic Compounds, 4 or More Rings | 1 | 2017 | 139 | 0.15 | Why? |
| Drug Therapy | 1 | 2018 | 280 | 0.15 | Why? |
| Caribbean Region | 1 | 2017 | 349 | 0.15 | Why? |
| Kenya | 1 | 2019 | 887 | 0.15 | Why? |
| Patents as Topic | 1 | 2018 | 224 | 0.15 | Why? |
| Drug Discovery | 2 | 2020 | 3092 | 0.15 | Why? |
| Histamine Antagonists | 1 | 2017 | 203 | 0.15 | Why? |
| Histones | 1 | 2018 | 371 | 0.15 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.15 | Why? |
| Flavanones | 1 | 2017 | 141 | 0.15 | Why? |
| Adaptation, Physiological | 1 | 2018 | 359 | 0.15 | Why? |
| Antiparasitic Agents | 1 | 2018 | 267 | 0.15 | Why? |
| Models, Genetic | 1 | 2017 | 434 | 0.14 | Why? |
| Promoter Regions, Genetic | 1 | 2019 | 823 | 0.14 | Why? |
| Plants | 1 | 2017 | 247 | 0.14 | Why? |
| Antineoplastic Agents, Hormonal | 1 | 2017 | 203 | 0.14 | Why? |
| Cellular Reprogramming Techniques | 1 | 2015 | 43 | 0.14 | Why? |
| Fibroblasts | 1 | 2019 | 839 | 0.14 | Why? |
| Herpesvirus 4, Human | 1 | 2018 | 387 | 0.14 | Why? |
| Esters | 1 | 2017 | 300 | 0.14 | Why? |
| Complementary Therapies | 1 | 2018 | 280 | 0.14 | Why? |
| DNA, Single-Stranded | 1 | 2015 | 95 | 0.14 | Why? |
| Substrate Specificity | 1 | 2016 | 639 | 0.14 | Why? |
| Biodiversity | 1 | 2018 | 546 | 0.14 | Why? |
| Bile Duct Neoplasms | 1 | 2017 | 172 | 0.14 | Why? |
| Chemoprevention | 1 | 2019 | 585 | 0.14 | Why? |
| Kaempferols | 1 | 2014 | 33 | 0.14 | Why? |
| Quality Control | 1 | 2018 | 628 | 0.14 | Why? |
| Gene Library | 1 | 2015 | 234 | 0.14 | Why? |
| Colonic Neoplasms | 1 | 2018 | 295 | 0.14 | Why? |
| European Union | 1 | 2018 | 565 | 0.13 | Why? |
| Chalcones | 1 | 2014 | 83 | 0.13 | Why? |
| Fluoresceins | 1 | 2013 | 46 | 0.13 | Why? |
| Carrier Proteins | 1 | 2017 | 513 | 0.13 | Why? |
| Cell Culture Techniques | 1 | 2018 | 704 | 0.13 | Why? |
| Fluorouracil | 3 | 2018 | 169 | 0.13 | Why? |
| Drug Synergism | 1 | 2017 | 833 | 0.13 | Why? |
| RNA, Small Interfering | 1 | 2018 | 817 | 0.13 | Why? |
| Water | 1 | 2018 | 765 | 0.13 | Why? |
| Sequence Deletion | 1 | 2017 | 674 | 0.13 | Why? |
| Stress, Psychological | 1 | 2016 | 10231 | 0.13 | Why? |
| Stem Cell Transplantation | 1 | 2018 | 531 | 0.12 | Why? |
| Chromatography, Affinity | 1 | 2015 | 310 | 0.12 | Why? |
| Substance Abuse Detection | 1 | 2015 | 192 | 0.12 | Why? |
| RNA, Messenger | 2 | 2019 | 5131 | 0.12 | Why? |
| Cyclophosphamide | 3 | 2018 | 387 | 0.12 | Why? |
| Risk Assessment | 1 | 2016 | 25439 | 0.12 | Why? |
| Cardiovascular Agents | 1 | 2018 | 663 | 0.12 | Why? |
| Anxiety | 1 | 2018 | 17311 | 0.12 | Why? |
| A549 Cells | 1 | 2018 | 2066 | 0.12 | Why? |
| Environmental Pollutants | 1 | 2017 | 320 | 0.12 | Why? |
| Thermodynamics | 3 | 2021 | 873 | 0.11 | Why? |
| Cysteine Endopeptidases | 1 | 2020 | 1557 | 0.11 | Why? |
| Ascorbic Acid | 1 | 2017 | 676 | 0.11 | Why? |
| Neurons | 1 | 2017 | 864 | 0.11 | Why? |
| Rats | 1 | 2018 | 2764 | 0.11 | Why? |
| Up-Regulation | 1 | 2019 | 2249 | 0.11 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.11 | Why? |
| Acute Lung Injury | 1 | 2019 | 904 | 0.10 | Why? |
| Protease Inhibitors | 3 | 2021 | 3630 | 0.10 | Why? |
| Brain Neoplasms | 1 | 2017 | 669 | 0.10 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.10 | Why? |
| Drug Interactions | 1 | 2017 | 1653 | 0.10 | Why? |
| Epirubicin | 2 | 2018 | 21 | 0.10 | Why? |
| Receptors, Glucocorticoid | 1 | 2010 | 118 | 0.09 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 1454 | 0.09 | Why? |
| Andrographis | 2 | 2018 | 42 | 0.09 | Why? |
| Vitamins | 1 | 2017 | 1208 | 0.09 | Why? |
| Molecular Targeted Therapy | 1 | 2017 | 1579 | 0.09 | Why? |
| Medicine, Chinese Traditional | 1 | 2020 | 2255 | 0.09 | Why? |
| Metabolic Networks and Pathways | 1 | 2010 | 285 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Tumor Cells, Cultured | 2 | 2018 | 254 | 0.09 | Why? |
| Combined Modality Therapy | 1 | 2017 | 3395 | 0.09 | Why? |
| Molecular Conformation | 2 | 2019 | 374 | 0.09 | Why? |
| Multiple Myeloma | 1 | 2017 | 1064 | 0.08 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.08 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.08 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.08 | Why? |
| Fruit | 2 | 2018 | 313 | 0.08 | Why? |
| Clinical Trials as Topic | 3 | 2020 | 7330 | 0.08 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.08 | Why? |
| Interleukin-1 | 1 | 2010 | 438 | 0.08 | Why? |
| Liver Neoplasms | 1 | 2018 | 1666 | 0.08 | Why? |
| HEK293 Cells | 1 | 2019 | 8394 | 0.07 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.07 | Why? |
| Molecular Sequence Data | 1 | 2010 | 3198 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.07 | Why? |
| Poultry Diseases | 1 | 2010 | 588 | 0.07 | Why? |
| Chickens | 1 | 2010 | 1010 | 0.07 | Why? |
| Aging | 1 | 2021 | 3581 | 0.07 | Why? |
| Neoplasm Metastasis | 2 | 2018 | 682 | 0.07 | Why? |
| Sequence Alignment | 1 | 2010 | 2109 | 0.07 | Why? |
| Periodicals as Topic | 1 | 2017 | 1492 | 0.07 | Why? |
| Female | 9 | 2018 | 380317 | 0.06 | Why? |
| Interleukin-10 | 1 | 2010 | 1409 | 0.06 | Why? |
| Nitric Oxide | 1 | 2010 | 769 | 0.06 | Why? |
| Viral Nonstructural Proteins | 1 | 2020 | 4810 | 0.06 | Why? |
| Electrocardiography | 1 | 2016 | 3957 | 0.06 | Why? |
| Developing Countries | 1 | 2018 | 4283 | 0.06 | Why? |
| Survival Rate | 1 | 2016 | 9206 | 0.06 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.06 | Why? |
| Brain | 1 | 2018 | 5133 | 0.05 | Why? |
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2019 | 16 | 0.05 | Why? |
| Interleukin-6 | 1 | 2018 | 7522 | 0.05 | Why? |
| Pentacyclic Triterpenes | 1 | 2019 | 45 | 0.05 | Why? |
| Protein Conformation | 1 | 2010 | 4386 | 0.05 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.05 | Why? |
| Synovial Membrane | 1 | 2019 | 72 | 0.05 | Why? |
| ADAMTS5 Protein | 1 | 2018 | 2 | 0.05 | Why? |
| Ultrasonic Waves | 1 | 2019 | 32 | 0.05 | Why? |
| Parasitic Sensitivity Tests | 1 | 2018 | 10 | 0.05 | Why? |
| Boswellia | 1 | 2018 | 13 | 0.05 | Why? |
| Magnolia | 1 | 2018 | 3 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.05 | Why? |
| Anisoles | 1 | 2018 | 4 | 0.05 | Why? |
| Male | 6 | 2019 | 367725 | 0.05 | Why? |
| Cyclization | 1 | 2018 | 46 | 0.05 | Why? |
| Africa, Central | 1 | 2018 | 29 | 0.05 | Why? |
| Cytisus | 1 | 2017 | 1 | 0.05 | Why? |
| Amino Acid Sequence | 1 | 2010 | 6049 | 0.05 | Why? |
| Mice, Inbred ICR | 1 | 2019 | 242 | 0.05 | Why? |
| Hydrogen Bonding | 1 | 2021 | 599 | 0.05 | Why? |
| Stereoisomerism | 1 | 2018 | 121 | 0.05 | Why? |
| Hydrolysis | 1 | 2018 | 160 | 0.05 | Why? |
| Glycosides | 1 | 2019 | 94 | 0.04 | Why? |
| Solvents | 1 | 2019 | 139 | 0.04 | Why? |
| Hypericum | 1 | 2017 | 29 | 0.04 | Why? |
| Neurotoxicity Syndromes | 1 | 2018 | 124 | 0.04 | Why? |
| Furans | 1 | 2019 | 156 | 0.04 | Why? |
| M Phase Cell Cycle Checkpoints | 1 | 2017 | 9 | 0.04 | Why? |
| G2 Phase Cell Cycle Checkpoints | 1 | 2017 | 25 | 0.04 | Why? |
| Maximum Tolerated Dose | 1 | 2017 | 65 | 0.04 | Why? |
| Algeria | 1 | 2017 | 185 | 0.04 | Why? |
| Quantum Theory | 1 | 2018 | 169 | 0.04 | Why? |
| Cells, Cultured | 2 | 2019 | 5835 | 0.04 | Why? |
| THP-1 Cells | 1 | 2018 | 374 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Enzyme Induction | 1 | 2017 | 89 | 0.04 | Why? |
| Bile Ducts | 1 | 2017 | 84 | 0.04 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2018 | 343 | 0.04 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.04 | Why? |
| DNA Topoisomerases, Type I | 1 | 2017 | 86 | 0.04 | Why? |
| Surface-Active Agents | 1 | 2019 | 267 | 0.04 | Why? |
| Plant Preparations | 1 | 2020 | 276 | 0.04 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.04 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.04 | Why? |
| Receptor Protein-Tyrosine Kinases | 1 | 2017 | 243 | 0.04 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2019 | 669 | 0.04 | Why? |
| Viral Proteins | 1 | 2014 | 7370 | 0.04 | Why? |
| Xenopus | 1 | 2014 | 13 | 0.04 | Why? |
| Mutagenesis | 1 | 2017 | 394 | 0.03 | Why? |
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2017 | 277 | 0.03 | Why? |
| Patch-Clamp Techniques | 1 | 2014 | 49 | 0.03 | Why? |
| Incidence | 1 | 2016 | 25622 | 0.03 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.03 | Why? |
| Lipopolysaccharides | 1 | 2019 | 848 | 0.03 | Why? |
| Narcotic Antagonists | 1 | 2018 | 317 | 0.03 | Why? |
| Mice, Knockout | 1 | 2019 | 1815 | 0.03 | Why? |
| Compassionate Use Trials | 1 | 2018 | 632 | 0.03 | Why? |
| Chromatography, Liquid | 1 | 2017 | 640 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Peptide Hydrolases | 1 | 2021 | 1269 | 0.03 | Why? |
| Cytomegalovirus | 1 | 2018 | 600 | 0.03 | Why? |
| Genetic Therapy | 1 | 2017 | 409 | 0.03 | Why? |
| Protein Structure, Tertiary | 1 | 2017 | 1565 | 0.03 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.03 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.03 | Why? |
| Mass Spectrometry | 1 | 2017 | 1165 | 0.03 | Why? |
| Autophagy | 1 | 2019 | 960 | 0.03 | Why? |
| Biomarkers | 1 | 2015 | 23361 | 0.03 | Why? |
| Natriuretic Peptide, Brain | 1 | 2018 | 1215 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Tandem Mass Spectrometry | 1 | 2017 | 1031 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2018 | 2689 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Kinetics | 1 | 2019 | 3238 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.03 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2014 | 881 | 0.02 | Why? |
| Child | 1 | 2018 | 70012 | 0.02 | Why? |
| Analgesics, Opioid | 1 | 2018 | 1070 | 0.02 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.02 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.02 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.02 | Why? |
| Disaster Planning | 1 | 2020 | 1680 | 0.02 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.02 | Why? |
| Risk Factors | 1 | 2016 | 71621 | 0.02 | Why? |
| Treatment Outcome | 3 | 2018 | 51732 | 0.02 | Why? |
| Turkey | 1 | 2017 | 3937 | 0.02 | Why? |
| Lopinavir | 1 | 2021 | 4308 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Epithelial Cells | 1 | 2017 | 3508 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Liver | 1 | 2018 | 4007 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2014 | 5814 | 0.02 | Why? |
| Vero Cells | 1 | 2019 | 14117 | 0.01 | Why? |
| Viral Envelope Proteins | 1 | 2014 | 3539 | 0.01 | Why? |
| Aged | 2 | 2018 | 215776 | 0.01 | Why? |
| Adult | 2 | 2018 | 244371 | 0.01 | Why? |
| Middle Aged | 2 | 2018 | 270681 | 0.01 | Why? |